Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia

Momcilo Jankovic, Donatella Fraschini, Augusto Amici, Maurizio Aricò, Alberto Arrighini, Giuseppe Basso, Roberto Colella, Maria Teresa DiTullio, Riccardo Haupt, Pierantonio Macchia, Saverio Magro, Antonia Mancini, Carla Manganini, Giovanna Meloni, Roberto Miniero, Paolo Rosso, Paola Saracco, Benedetto Terracini, Giuseppe Masera

Research output: Contribution to journalArticle

Abstract

A total of 2192 children with acute lymphoblastic leukaemia who had reached cessation of therapy in complete remission were followed for a median time of 52 months after treatment suspension. Of the 485 relapses observed, 62.3% occurred in the first year off therapy and 68.9% involved the bone marrow. Eight relapses were reported more than 5 years (62-143 months) after treatment withdrawal. Males fared worse than females consistently, experiencing 1.5 times more relapses (P <0.0001). Thirteen patients died in continuous complete remission, 5 because of non-neoplastic central nervous system complications. There were 11 second solid malignancies, 8 of them in the central nervous system; 9 subjects presented an haematopoietic malignancy after ALL. The projected event-free survival at 8 years is 73%. Twenty-two of the 171 young adults (age > 20 years) were married and 16 have had 21 healthy children. Twenty-four per cent of patients experienced an unfavourable event. Relapses accounted for 93% of failures. Central nervous system late effects and second malignancies were the major causes of non-leukaemic morbidity and mortality.

Original languageEnglish
Pages (from-to)1839-1843
Number of pages5
JournalEuropean Journal of Cancer
Volume29
Issue number13
DOIs
Publication statusPublished - 1993

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Second Primary Neoplasms
Therapeutics
Suspensions
Central Nervous System
Bone Marrow
Morbidity
Mortality

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Jankovic, M., Fraschini, D., Amici, A., Aricò, M., Arrighini, A., Basso, G., ... Masera, G. (1993). Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. European Journal of Cancer, 29(13), 1839-1843. https://doi.org/10.1016/0959-8049(93)90533-L

Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. / Jankovic, Momcilo; Fraschini, Donatella; Amici, Augusto; Aricò, Maurizio; Arrighini, Alberto; Basso, Giuseppe; Colella, Roberto; Teresa DiTullio, Maria; Haupt, Riccardo; Macchia, Pierantonio; Magro, Saverio; Mancini, Antonia; Manganini, Carla; Meloni, Giovanna; Miniero, Roberto; Rosso, Paolo; Saracco, Paola; Terracini, Benedetto; Masera, Giuseppe.

In: European Journal of Cancer, Vol. 29, No. 13, 1993, p. 1839-1843.

Research output: Contribution to journalArticle

Jankovic, M, Fraschini, D, Amici, A, Aricò, M, Arrighini, A, Basso, G, Colella, R, Teresa DiTullio, M, Haupt, R, Macchia, P, Magro, S, Mancini, A, Manganini, C, Meloni, G, Miniero, R, Rosso, P, Saracco, P, Terracini, B & Masera, G 1993, 'Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia', European Journal of Cancer, vol. 29, no. 13, pp. 1839-1843. https://doi.org/10.1016/0959-8049(93)90533-L
Jankovic M, Fraschini D, Amici A, Aricò M, Arrighini A, Basso G et al. Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. European Journal of Cancer. 1993;29(13):1839-1843. https://doi.org/10.1016/0959-8049(93)90533-L
Jankovic, Momcilo ; Fraschini, Donatella ; Amici, Augusto ; Aricò, Maurizio ; Arrighini, Alberto ; Basso, Giuseppe ; Colella, Roberto ; Teresa DiTullio, Maria ; Haupt, Riccardo ; Macchia, Pierantonio ; Magro, Saverio ; Mancini, Antonia ; Manganini, Carla ; Meloni, Giovanna ; Miniero, Roberto ; Rosso, Paolo ; Saracco, Paola ; Terracini, Benedetto ; Masera, Giuseppe. / Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. In: European Journal of Cancer. 1993 ; Vol. 29, No. 13. pp. 1839-1843.
@article{a0d094741f3b49a4b8cd3198d1c82147,
title = "Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia",
abstract = "A total of 2192 children with acute lymphoblastic leukaemia who had reached cessation of therapy in complete remission were followed for a median time of 52 months after treatment suspension. Of the 485 relapses observed, 62.3{\%} occurred in the first year off therapy and 68.9{\%} involved the bone marrow. Eight relapses were reported more than 5 years (62-143 months) after treatment withdrawal. Males fared worse than females consistently, experiencing 1.5 times more relapses (P <0.0001). Thirteen patients died in continuous complete remission, 5 because of non-neoplastic central nervous system complications. There were 11 second solid malignancies, 8 of them in the central nervous system; 9 subjects presented an haematopoietic malignancy after ALL. The projected event-free survival at 8 years is 73{\%}. Twenty-two of the 171 young adults (age > 20 years) were married and 16 have had 21 healthy children. Twenty-four per cent of patients experienced an unfavourable event. Relapses accounted for 93{\%} of failures. Central nervous system late effects and second malignancies were the major causes of non-leukaemic morbidity and mortality.",
author = "Momcilo Jankovic and Donatella Fraschini and Augusto Amici and Maurizio Aric{\`o} and Alberto Arrighini and Giuseppe Basso and Roberto Colella and {Teresa DiTullio}, Maria and Riccardo Haupt and Pierantonio Macchia and Saverio Magro and Antonia Mancini and Carla Manganini and Giovanna Meloni and Roberto Miniero and Paolo Rosso and Paola Saracco and Benedetto Terracini and Giuseppe Masera",
year = "1993",
doi = "10.1016/0959-8049(93)90533-L",
language = "English",
volume = "29",
pages = "1839--1843",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "13",

}

TY - JOUR

T1 - Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia

AU - Jankovic, Momcilo

AU - Fraschini, Donatella

AU - Amici, Augusto

AU - Aricò, Maurizio

AU - Arrighini, Alberto

AU - Basso, Giuseppe

AU - Colella, Roberto

AU - Teresa DiTullio, Maria

AU - Haupt, Riccardo

AU - Macchia, Pierantonio

AU - Magro, Saverio

AU - Mancini, Antonia

AU - Manganini, Carla

AU - Meloni, Giovanna

AU - Miniero, Roberto

AU - Rosso, Paolo

AU - Saracco, Paola

AU - Terracini, Benedetto

AU - Masera, Giuseppe

PY - 1993

Y1 - 1993

N2 - A total of 2192 children with acute lymphoblastic leukaemia who had reached cessation of therapy in complete remission were followed for a median time of 52 months after treatment suspension. Of the 485 relapses observed, 62.3% occurred in the first year off therapy and 68.9% involved the bone marrow. Eight relapses were reported more than 5 years (62-143 months) after treatment withdrawal. Males fared worse than females consistently, experiencing 1.5 times more relapses (P <0.0001). Thirteen patients died in continuous complete remission, 5 because of non-neoplastic central nervous system complications. There were 11 second solid malignancies, 8 of them in the central nervous system; 9 subjects presented an haematopoietic malignancy after ALL. The projected event-free survival at 8 years is 73%. Twenty-two of the 171 young adults (age > 20 years) were married and 16 have had 21 healthy children. Twenty-four per cent of patients experienced an unfavourable event. Relapses accounted for 93% of failures. Central nervous system late effects and second malignancies were the major causes of non-leukaemic morbidity and mortality.

AB - A total of 2192 children with acute lymphoblastic leukaemia who had reached cessation of therapy in complete remission were followed for a median time of 52 months after treatment suspension. Of the 485 relapses observed, 62.3% occurred in the first year off therapy and 68.9% involved the bone marrow. Eight relapses were reported more than 5 years (62-143 months) after treatment withdrawal. Males fared worse than females consistently, experiencing 1.5 times more relapses (P <0.0001). Thirteen patients died in continuous complete remission, 5 because of non-neoplastic central nervous system complications. There were 11 second solid malignancies, 8 of them in the central nervous system; 9 subjects presented an haematopoietic malignancy after ALL. The projected event-free survival at 8 years is 73%. Twenty-two of the 171 young adults (age > 20 years) were married and 16 have had 21 healthy children. Twenty-four per cent of patients experienced an unfavourable event. Relapses accounted for 93% of failures. Central nervous system late effects and second malignancies were the major causes of non-leukaemic morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=0027493773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027493773&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(93)90533-L

DO - 10.1016/0959-8049(93)90533-L

M3 - Article

C2 - 8260237

AN - SCOPUS:0027493773

VL - 29

SP - 1839

EP - 1843

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 13

ER -